Literature DB >> 20713992

Routes of transmission of hepatitis C virus.

Alejandro Soza1, Arnoldo Riquelme, Marco Arrese.   

Abstract

Hepatitis C is one of the most common causes of chronic liver disease in Latin America. It is essential to understand the different mechanisms of transmission of the infection in order to design control measures. The pattern of transmission of the infection in our region suggests that the peak of the infection occurred 30 to 50 years ago. While most infections in Latin America seem to be the result of blood transfusion and unsafe therapeutic injection practices in the past, there is still a need to identify and notify infected blood donors. Intravenous drug use and sexually transmitted hepatitis C virus among human immunodeficiency virus-positive patients are current problems that need to be addressed.

Entities:  

Mesh:

Year:  2010        PMID: 20713992

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  3 in total

1.  Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population--how is the epidemiological situation?

Authors:  Mónica Viviana Alvarado-Mora; María Fernanda Gutierrez Fernandez; Michele Soares Gomes-Gouvêa; Raymundo Soares de Azevedo Neto; Flair José Carrilho; João Renato Rebello Pinho
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

2.  Expanded Diversity and Host Range of Bovine Hepacivirus-Genomic and Serological Evidence in Domestic and Wild Ruminant Species.

Authors:  Jana Breitfeld; Nicole Fischer; Ilia Tsachev; Plamen Marutsov; Magdalena Baymakova; Radim Plhal; Oliver Keuling; Paul Becher; Christine Baechlein
Journal:  Viruses       Date:  2022-06-30       Impact factor: 5.818

Review 3.  The Role of the Microbiota Gut-Liver Axis during HCV Chronic Infection: A Schematic Overview.

Authors:  Nadia Marascio; Carmen De Caro; Angela Quirino; Maria Mazzitelli; Emilio Russo; Carlo Torti; Giovanni Matera
Journal:  J Clin Med       Date:  2022-10-08       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.